Powered by

Fennec Pharmaceuticals increases 1.7% - outperforming 81% of stocks March 01, 2017 17:00 EST

Mar 1, 2017 - News Bites Canadian Markets


Fennec Pharmaceuticals Inc. (TSX:FRX), Canada's 25th largest Biotechnology company by market cap, has increased 6.0c (1.7%) from its last trading session of February 28 to close at CAD3.51. Compared with the S&P/TSX 60 Index which rose 11.1 points (1.2%) in the day, the relative price increase was 0.5%. The volume was 0.01 times the average daily trading volume of 42,483 shares. In the Canadian market of 1,922 stocks and 88 units traded today, the stock has a 6-

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox